Holen Sie sich die Stockscreener-App
608.41
1.70%
-10.51
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt IDXX?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$618.92
Offen:
$607.59
24-Stunden-Volumen:
560.40K
Relative Volume:
1.09
Marktkapitalisierung:
$48.44B
Einnahmen:
$4.30B
Nettoeinkommen (Verlust:
$1.06B
KGV:
46.52
EPS:
13.0798
Netto-Cashflow:
$1.04B
1W Leistung:
-7.36%
1M Leistung:
-5.62%
6M Leistung:
-5.38%
1J Leistung:
+41.81%
1-Tages-Spanne:
$594.94
$615.48
1-Wochen-Bereich:
$594.94
$651.06
52-Wochen-Spanne:
$356.14
$769.98
Idexx Laboratories Inc Stock (IDXX) Company Profile
Firmenname
Idexx Laboratories Inc
Sektor
Branche
Telefon
(207) 556-0300
Adresse
ONE IDEXX DRIVE, WESTBROOK, ME
Compare IDXX vs TMO, DHR, A, WAT
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IDXX
Idexx Laboratories Inc
|
608.41 | 49.28B | 4.30B | 1.06B | 1.04B | 13.08 |
|
TMO
Thermo Fisher Scientific Inc
|
501.97 | 194.93B | 44.56B | 6.72B | 6.29B | 17.74 |
|
DHR
Danaher Corp
|
195.50 | 142.84B | 24.57B | 3.60B | 5.26B | 5.051 |
|
A
Agilent Technologies Inc
|
115.07 | 33.38B | 6.95B | 1.30B | 1.15B | 4.5696 |
|
WAT
Waters Corp
|
302.54 | 30.96B | 3.17B | 642.63M | 516.49M | 10.77 |
Idexx Laboratories Inc Stock (IDXX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-09 | Eingeleitet | Barclays | Overweight |
| 2025-10-31 | Hochstufung | Stifel | Hold → Buy |
| 2025-10-01 | Eingeleitet | UBS | Neutral |
| 2025-08-05 | Bestätigt | BTIG Research | Buy |
| 2025-07-01 | Eingeleitet | Jefferies | Buy |
| 2024-12-02 | Eingeleitet | Leerink Partners | Outperform |
| 2024-07-25 | Eingeleitet | BTIG Research | Buy |
| 2024-01-30 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2023-12-07 | Eingeleitet | Exane BNP Paribas | Outperform |
| 2023-12-04 | Hochstufung | Cleveland Research | Neutral → Buy |
| 2023-08-02 | Herabstufung | Atlantic Equities | Overweight → Neutral |
| 2022-07-25 | Herabstufung | Stifel | Buy → Hold |
| 2022-07-21 | Hochstufung | Goldman | Neutral → Buy |
| 2022-07-12 | Eingeleitet | Piper Sandler | Overweight |
| 2022-05-05 | Herabstufung | BofA Securities | Buy → Neutral |
| 2022-02-08 | Eingeleitet | Atlantic Equities | Overweight |
| 2021-11-18 | Eingeleitet | Morgan Stanley | Overweight |
| 2021-08-05 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-07-12 | Herabstufung | Guggenheim | Buy → Neutral |
| 2021-02-17 | Eingeleitet | Barclays | Overweight |
| 2019-09-09 | Eingeleitet | Goldman | Neutral |
| 2019-05-23 | Eingeleitet | Guggenheim | Buy |
| 2018-11-02 | Bestätigt | BofA/Merrill | Buy |
| 2018-05-07 | Bestätigt | Stifel | Buy |
| 2018-01-16 | Eingeleitet | Piper Jaffray | Overweight |
| 2017-08-23 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2017-07-28 | Hochstufung | CL King | Neutral → Buy |
| 2017-02-03 | Herabstufung | Feltl & Co. | Hold → Sell |
| 2016-09-29 | Fortgesetzt | BofA/Merrill | Neutral |
| 2016-08-16 | Bestätigt | Stifel | Buy |
| 2016-08-03 | Hochstufung | Northcoast | Sell → Neutral |
| 2016-07-20 | Bestätigt | Canaccord Genuity | Buy |
| 2016-04-19 | Bestätigt | Canaccord Genuity | Buy |
| 2016-04-01 | Eingeleitet | CL King | Neutral |
| 2016-03-21 | Bestätigt | Stifel | Buy |
| 2016-02-04 | Eingeleitet | Credit Suisse | Outperform |
| 2015-10-29 | Bestätigt | Stifel | Buy |
| 2015-08-28 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2015-08-13 | Bestätigt | Stifel | Buy |
| 2015-07-23 | Bestätigt | Canaccord Genuity | Buy |
Alle ansehen
Idexx Laboratories Inc Aktie (IDXX) Neueste Nachrichten
IDEXX Laboratories Stock Hits Day Low of $614.25 Amid Price Pressure - Markets Mojo
Is This the Right Time to Retain IDXX Stock in Your Portfolio? - TradingView
GW&K Investment Management LLC Trims Holdings in IDEXX Laboratories, Inc. $IDXX - MarketBeat
IDEXX Laboratories, Inc. $IDXX Position Reduced by Dimensional Fund Advisors LP - MarketBeat
IDEXX Laboratories (NASDAQ:IDXX) EVP Sells $1,115,574.06 in Stock - MarketBeat
Idexx Launch of InVue Provides Path to Recurring Revenue - Morningstar
IDEXX Laboratories, Inc. $IDXX Holdings Increased by Victory Capital Management Inc. - MarketBeat
IDEXX Laboratories, Inc. $IDXX Shares Sold by Segall Bryant & Hamill LLC - MarketBeat
Why Is Idexx (IDXX) Up 0.5% Since Last Earnings Report? - Yahoo Finance
New Age Alpha Advisors LLC Increases Stock Position in IDEXX Laboratories, Inc. $IDXX - MarketBeat
IDEXX Laboratories (NASDAQ:IDXX) CEO Sells $15,338,011.30 in Stock - MarketBeat
IDEXX Laboratories CEO Jonathan Jay Mazelsky Sells Over 23,000 Shares - TradingView
IDEXX Laboratories Inc. stock underperforms Monday when compared to competitors - MarketWatch
IDEXX Laboratories, Inc. (IDXX) - DirectorsTalk Interviews
IDEXX Laboratories Inc (IDXX) Shares Down 3.69% on Mar 2 - GuruFocus
IDEXX Labs at Raymond James Conference: Innovation and Growth Strategy - Investing.com Nigeria
Transcript : IDEXX Laboratories, Inc. Presents at 47th Annual Raymond James Institutional Investor Conference, Mar-02-2026 09 - marketscreener.com
IDEXX Laboratories Inc (IDXX) Stock Price & 30 Year Financial Data - GuruFocus
IDXX Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
IDEXX Laboratories, Inc. $IDXX Shares Sold by Davis R M Inc. - MarketBeat
Aster Capital Management DIFC Ltd Sells 3,735 Shares of IDEXX Laboratories, Inc. $IDXX - MarketBeat
Analysis Recap: Can IDEXX Laboratories Inc keep up with sector leaders2025 Key Lessons & Proven Capital Preservation Tips - baoquankhu1.vn
William Blair Investment Management LLC Trims Holdings in IDEXX Laboratories, Inc. $IDXX - MarketBeat
Rafferty Asset Management LLC Sells 3,443 Shares of IDEXX Laboratories, Inc. $IDXX - MarketBeat
Andra AP fonden Boosts Stake in IDEXX Laboratories - National Today
Erste Asset Management GmbH Sells 4,665 Shares of IDEXX Laboratories, Inc. $IDXX - MarketBeat
Andra AP fonden Raises Position in IDEXX Laboratories, Inc. $IDXX - MarketBeat
American Century Companies Inc. Has $450.52 Million Stock Holdings in IDEXX Laboratories, Inc. $IDXX - MarketBeat
Wall Street Zen Downgrades IDEXX Laboratories (NASDAQ:IDXX) to Buy - MarketBeat
IDEXX Laboratories Touts “Exceptional” Q4, Targets 8%-10% 2026 Growth at BofA Summit - MarketBeat
Insider Selling: IDEXX Laboratories (NASDAQ:IDXX) EVP Sells 2,693 Shares of Stock - MarketBeat
IDEXX Laboratories Executive Sells Shares - TradingView
Stifel Maintains IDEXX Laboratories Inc(IDXX.US) With Buy Rating, Maintains Target Price $775 - 富途牛牛
94,129 Shares in IDEXX Laboratories, Inc. $IDXX Purchased by Westfield Capital Management Co. LP - MarketBeat
IDEXX Laboratories, Inc. $IDXX Stake Raised by Mitsubishi UFJ Asset Management Co. Ltd. - MarketBeat
Reasons why hedge funds still fancy IDEXX Laboratories, Inc. (IDXX) - MSN
[144] IDEXX LABORATORIES INC /DE SEC Filing - Stock Titan
IDEXX Labs at BofA Summit: Strong Growth Amid Challenges - Investing.com Nigeria
Montrusco Bolton Investments Inc. Cuts Holdings in IDEXX Laboratories, Inc. $IDXX - MarketBeat
TD Asset Management Inc Sells 25,321 Shares of IDEXX Laboratories, Inc. $IDXX - MarketBeat
IDEXX Laboratories Inc. stock outperforms competitors on strong trading day - MarketWatch
BofA Securities Maintains IDEXX Laboratories Inc(IDXX.US) With Hold Rating, Maintains Target Price $790 - 富途牛牛
Investment Review: Can IDEXX Laboratories Inc sustain earnings growthQuarterly Portfolio Report & Weekly Breakout Watchlists - baoquankhu1.vn
IDXX SEC FilingsIDEXX Laboratories 10-K, 10-Q, 8-K Forms - Stock Titan
Waratah Capital Advisors Ltd. Cuts Stock Position in IDEXX Laboratories, Inc. $IDXX - MarketBeat
Weitz Investment Management Inc. Lowers Holdings in IDEXX Laboratories, Inc. $IDXX - MarketBeat
Jacobson & Schmitt Advisors LLC Sells 6,794 Shares of IDEXX Laboratories, Inc. $IDXX - MarketBeat
Dakota Wealth Management Raises Position in IDEXX Laboratories, Inc. $IDXX - MarketBeat
IDEXX Laboratories Inc (IDXX) Shares Up 3.23% on Feb 24 - GuruFocus
IDEXX Laboratories (IDXX) Rallied in Q2. Here’s Why - MSN
Breakouts Watch: Is IDEXX Laboratories Inc attractive for institutional investorsWeekly Investment Recap & Accurate Buy Signal Alerts - baoquankhu1.vn
Finanzdaten der Idexx Laboratories Inc-Aktie (IDXX)
Umsatz
Nettogewinn
Free Cashflow
ENV
Idexx Laboratories Inc-Aktie (IDXX) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Hunt Nimrata | Executive Vice President |
Mar 03 '26 |
Sale |
634.57 |
1,758 |
1,115,577 |
18,141 |
2.57%
0.50%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):